Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC

  1. Bauer, T.M.
  2. Besse, B.
  3. Martinez-Marti, A.
  4. Trigo, J.M.
  5. Moreno, V.
  6. Garrido, P.
  7. Ferron-Brady, G.
  8. Wu, Y.
  9. Park, J.
  10. Collingwood, T.
  11. Kruger, R.G.
  12. Mohammad, H.P.
  13. Ballas, M.S.
  14. Dhar, A.
  15. Govindan, R.
Revue:
Journal of Thoracic Oncology

ISSN: 1556-1380,  1556-0864

Année de publication: 2019

Volumen: 14

Número: 10

Pages: 1828-1838

Type: Article

DOI: 10.1016/J.JTHO.2019.06.021 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus